Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
477 A novel antibody targeting human monocyte-intrinsic PD-L1 promotes immune stimulatory functions of monocytes for antitumor immunity
Compose a Response to This Article
Other responses
No responses have been published for this article.
